Brassinosteroids (BRs) are growth-promoting steroid hormones in plants. Genetic studies in Arabidopsis illustrated the essential roles of BRs in a wide range of developmental processes and helped identify many genes involved in BR biosynthesis and signal transduction. Recently, proteomic studies identified missing links. Together, these approaches established the BR signal transduction cascade, which includes BR perception by the BRI1 receptor kinase at the cell surface, activation of BRI1/BAK1 kinase complex by transphosphorylation, subsequent phosphorylation of the BSK kinases, activation of the BSU1 phosphatase, dephosphorylation and inactivation of the BIN2 kinase, and accumulation of unphosphorylated BZR transcription factors in the nucleus. Mass spectrometric analyses are providing detailed information on the phosphorylation events involved in each step of signal relay. Thus, the BR signaling pathway provides a paradigm for understanding receptor kinase-mediated signal transduction as well as tools for the genetic improvement of the productivity of crop plants. 
INTRODUCTION
Steroids have long been known as hormones in metazoans (85) . Their hormonal activity in plants was only discovered about 30 years ago, when a growth-promoting activity in pollen extract of oilseed rape (Brassica napus) was attributed to a steroid compound named brassinolide (BL) (24) . Since then, steroids with similar structure and activities as BL have been identified in a variety of plants and are collectively called brassinosteroids (BRs) (13) . While hormone treatments demonstrated many physiological and developmental responses induced by exogenous BR, the essential function of BRs in plant development was not widely appreciated until BR-deficient and BRinsensitive mutants were identified in a relative of B. napus, the model organism Arabidopsis thaliana (12, 49, 81) . These mutants display many growth defects, including dwarfism, dark green leaves, delayed flowering, male sterility, and photomorphogenesis in complete darkness. Now BRs are considered essential hormones that regulate a wide range of developmental and physiological processes, such as cell elongation, vascular differentiation, root growth, responses to light, resistance to stresses, and senescence.
Arabidopsis mutants identified not only BR biosynthetic enzymes but also signaling proteins that perceive and transduce the BR signal. Forward genetic screens in Arabidopsis identified multiple alleles of two loci that cause BR insensitivity, bri1 and bin2. BR INSENSITIVE 1 (BRI1) encodes one of over 200 members of the leucine-rich repeat-receptor-like kinase (LRR-RLK) family in Arabidopsis (79) , and BR INSENSITIVE 2 (BIN2) encodes one of the 10 glycogen synthase kinase 3 (GSK3)-like kinases of Arabidopsis (50) . Sensitized genetic screens using the BR biosynthetic inhibitor brassinazole (BRZ) or weak alleles of bri1 as genetic background identified additional components of the pathway, including the BRASSINA-ZOLE RESISTANT 1 (BZR1) and bri1-EMS-SUPPRESSOR 1 (BES1) transcription factors (93, 97) , BRI1-ASSOCIATED RECEPTOR KINASE 1 (BAK1) (52, 60) , and bri1-SUPPRESSOR 1 (BSU1) phosphatase (57) (Figure 1 ). BES1 is 89% identical to BZR1 and was also named BZR2 (93) . BAK1 was also identified by yeast two-hybrid screening as a BRI1-interacting protein (60) .
Additional components of the BR signal transduction pathway have been identified as proteins that interact with these genetically defined components. The BRI1-interacting proteins include BAK1 (60), BRI1 KINASE INHIBITOR 1 (BKI1) (89) , and TRANSTHYRETIN-LIKE (TTL) (61) . The 14-3-3 proteins were identified as BZR1-and BZR2/BES1-interacting proteins (21, 70) . In addition, there is evidence that BES1/BZR2 The structures of BRI1 and BAK1. BRI1 is composed of 24 leucine-rich repeats (LRR) and a 70-amino-acid island domain (ID), single-pass transmembrane region (TM), juxtamembrane region ( JM), kinase domain (KD), and C-terminal (CT) region. BAK1 contains 4 leucine zippers (LZ), 5 LRRs, and a proline-rich region (pro-rich), single-pass TM, KD, and CT. The putative signal peptide region is shown as a black box and unassigned regions are shown as gray boxes. The activation loop of kinases is designated AL. The confirmed phosphorylation sites are marked with circles, and putative phosphorylation sites are marked with squares containing the letter P. The activation phosphorylation sites are shown in red, inhibitory sites in blue, and residues without significant effect on the kinase activity or not examined experimentally in yellow.
interacts with other transcription factors, including BIM1, ELF6, and Myb30 (53, 96, 98) . Proteomic studies identified additional components that filled the last gap in the pathway (84) , and biochemical studies assembled these components into a phosphorylation cascasde that connects BR perception at the cell surface to activation of transcription factors in the nucleus (42) . With the process in hand, detailed biochemical studies are revealing molecular mechanisms of receptor kinase activation (91, 92) , signal relay, and regulation of the BZR transcription factors by phosphorylation (21, 70, 86) . BR regulation of gene expression mediated by the BZR transcription factors has been covered in recent reviews (87) . This review focuses on how the BR signal is transduced from the cell surface receptor kinases to the nuclear transcription factors.
RECEPTOR ACTIVATION

BRI1 Perceives BRs at the Cell Surface
The brassinosteroid insensitive 1 (bri1) mutant was identified as a dwarf insensitive to BR treatment (12, 40) . Additional bri1 alleles helped to clone the BRI1 gene, which encodes an LRR-RLK (47) . The extracellular domain of BRI1 contains 24 leucine-rich repeats (LRRs) and an island domain (ID) between the twentieth and twenty-first LRRs; BRI1's cytoplasmic domain contains a serine/threonine (Ser/Thr) kinase domain, a juxtamembrane region ( JM), and the C-terminal extension (CT) (47, 87) (Figure 1) .
The function of BRI1 as the BR receptor has been demonstrated by several lines of experimental evidence. These include a chimeric receptor of BRI1-XA21 conferring BR-induced defense responses (29) , binding of BRI1 immunoprecipitated from Arabidopsis plants (94) or expressed and purified in Escherichia coli (43) to tritium-labeled BL ( 3 H-BL), and BRinduced BRI1 auto-phosphorylation (90, 91, 94) . It was further shown that the 94-aminoacid ID-LRR21 domain containing ID and its flanking LRR21 is sufficient for BR binding (43) . These studies demonstrated that BRI1 is the receptor of BRs and defined a new steroid-binding motif. BR binding to the extracellular domain activates the cytoplasmic kinase, which transduces the signal to other intracellular proteins.
Most of the mutations identified in the 28 bri1 alleles are clustered in either the ID-LRR21 or cytoplasmic kinase domain, consistent with an essential role of the BR binding and kinase activity for BRI1 function. Interestingly, some of the mutations in the extracellular domain, such as bri1-5 and bri1-9 alleles, cause retention of the mutant protein in the endoplasmic reticulum (ER) due to protein misfolding. Genetic screens for suppressors of these alleles have identified components of the ER quality-control system that mediate retention and processing of the misfolded bri1 proteins (34, 37) .
A domain-structure analysis also uncovered important roles for the JM and CT domains. Deletion of the JM domain abolished the signaling function of BRI1, suggesting a positive role for the JM in BRI1 function. In contrast, a truncated BRI1, with the C-terminal 49 amino acid residues deleted, displayed higher kinase activity in vitro and more complete rescue of the bri1 mutant phenotype in transgenic plants, suggesting an autoinhibitory role of the CT (92) . The CT region contains multiple phosphorylation sites, and mutation of these Ser/Thr residues to phosphomimetic acidic amino acids had effects similar to the deletion of this region, suggesting that phosphorylation of the CT region helps to activate the kinase. This may occur through a conformational change that releases the autoinhibition of the kinase by the C-terminal tail (92) .
hetero-oligomerization (67, 74) . For example, perception of TGFβ involves a homo-dimeric type I TGFβ receptor and a homo-dimeric type II TGFβ receptor. TGFβ binds to the type II receptor to promote its association with and phosphorylation of the type I receptor, which transduces the signal to downstream components. Similarly, BR signaling also involves ligand-induced BRI1 homodimerization or homo-oligomerization and hetero-oligomerization with a coreceptor kinase named BRI1-associated kinase 1 (BAK1).
Homo-dimerization of BRI1 was first detected using fluorescence resonance energy transfer (FRET) analysis in the plasma membrane (PM) of cowpea protoplasts (69) . Furthermore, using single molecule detection methods, it has been demonstrated that about 20% of BRI1 molecules in the PM are present in homo-dimerized form without higher-order oligomerization (31) . BRI1 homo-dimerization has also been detected by coimmunoprecipitation of BRI1-GFP and BRI1-FLAG fusion proteins from transgenic Arabidopsis plants (92) . Although BR had no effect on BRI1 homo-dimerization in protoplasts (31) , BR treatment of Arabidopsis plants increased the coimmunoprecipitation of BRI1-GFP and BRI1-FLAG, indicating that BR promotes or stabilizes BRI1 homo-dimerization (92) .
It is yet unclear whether BRs function as a molecular glue, in a manner similar to auxin-induced TIR1-IAA protein dimerization (82) , to help stabilize the BRI1 homo-dimer, or whether BR binding causes a conformational change that favors homo-dimerization. The latter possibility is supported by the estimated one BL molecule that is bound per BRI1-GFP molecule (43) . It is also unclear whether the kinase activity is required for BR-induced homo-dimerization of BRI1. Nevertheless, BR-induced homo-dimerization of BRI1 seems not sufficient to fully activate the BRI1 kinase, and further association with the coreceptor kinase BAK1 is required. BAK1 was identified independently by two research groups using a yeast two-hybrid screen for BRI1 interacting proteins and an activation tagging screen for bri1-5 suppressors (52, 60) . BAK1 is also named SERK3 and is one of the five SOMATIC EMBRYOGEN-ESIS RECEPTOR-LIKE KINASEs (SERK1 to SERK5) (75) , which are LRR-RLKs that contain a small extracellular domain with five LRRs (Figure 1) . Overexpression of BAK1 suppresses the phenotype of a weak bri1 allele (52, 60) . The bak1 loss-of-function mutant resembles weak bri1 mutants (52) , and overexpression of a kinase-inactive bak1 mutant protein causes severe dwarf phenotypes similar to strong bri1 mutants, presumably due to a dominant negative effect (52) . Recent genetic studies of loss-of-function mutations of BAK1/SERK3 and its homologs (SERK1 and SERK4) confirmed their essential roles in BR signaling, as well as in additional pathways (3, 28) .
The kinase domains of BRI1 and BAK1 interact with and trans-phosphorylate each other in vitro and in yeast (52, 60) , and their in vivo interaction has been detected by coimmunoprecipitation using transgenic Arabidopsis and FRET analysis in protoplasts (52, 60, 69) . Both BRI1 and BAK1 show basal levels of kinase activities in vitro, which are increased by the corresponding partner (52) . In yeast, kinase activity is detected only when wild type BRI1 and BAK1 are coexpressed but is not detected when either BRI1 or BAK1 is mutated or absent (60) . These results suggest that full activation of either receptor kinase requires transphosphorylation by its partner.
In Arabidopsis, BR treatment promotes the interaction between BRI1 and BAK1 and increases their phosphorylation (90, 91) . The BR-induced BRI1-BAK1 association seems to be mediated by their kinase domains rather than cooperative binding of the extracellular domains. First, BR binding to BRI1 appears to be independent of BAK1 and BAK1 does not participate in BR binding, because the BL binding activity of BRI1 was not altered in a bak1 null mutant or by overexpression of BAK1 (43, 92) . Second, the interaction between BRI1 and BAK1 requires their kinase activities. In vitro interaction is reduced by mutations of the BAK1 kinase domain and almost completely www.annualreviews.org • Brassinosteroid Signal Transductionabolished by kinase-inactive mutations of the BRI1 kinase domain (52) . A kinase-dead mutant BRI1 did not show BR-induced association with BAK1, indicating that intact extracellular domains are not sufficient and BRI1 kinase activity is required for BR-induced association with BAK1 (91) . However, the L46E mutation in the leucine zipper of BAK1 extracellular domain appeared to abolish BAK1 binding to BRI1 in yeast (99) . While this result supported a possible role of the extracellular domain in BRI1-BAK1 association, the lack of BRI1 interaction could also be due to a possible mislocalization (such as retention in the ER) or instability of the mutant BAK1 in the cell. On the other hand, a kinase-dead mutant BAK1 still associates with wild type BRI1 upon BR treatment, suggesting that BR first activates BRI1 kinase, and the association with BAK1 is a result of initial activation of the BRI1 kinase (91) . A requirement of BRI1 kinase activity for BAK1 interaction and activation is consistent with the observation that BAK1 overexpression suppresses only weak alleles of bri1 but not the bri1-5 det2 double mutant or bril null mutants (52, 60) . These results suggest that BAK1 is involved in BRI1 activation rather than transducing the BR signal to downstream substrates.
Team Play and Multitasking of the Receptor Kinases
BRI1 is the major BR receptor in higher plants. Mutations of the BRI1 orthologs in tomato, rice, and pea cause BR-insensitive phenotypes (55, 59, 62) . However, BRI1 is not the only BR receptor. There are three close homologs of BRI1 in Arabidopsis and at least two of them, BRL1 and BRL3, bind to BR with high affinity and can rescue the bri1 mutant when expressed from a BRI1 promoter (8, 43, 101) . These BRI1 homologs apparently mediate cell-type-specific BR response in vascular tissues (8) . Such functional specification of BRI1 homologs obviously occurred during evolution before the separation of monocots from dicots, since OsBRL1 and OsBRL3 also seem to mediate tissue-or cell-type-specific BR responses in rice (59) .
BAK1 also belongs to a small subfamily of RLKs called SOMATIC EMBRYOGENESIS RECEPTOR KINASES (SERK1 to SERK5). In addition to BAK1 (SERK3), two additional members of the SERK family, SERK1 and BKK1 (BAK1-like 1, SERK4), appear to play redundant roles with BAK1 in BR signaling. As with BAK1, overexpression of SERK1 or BKK1 partially suppresses the bri1-5 mutant, and they interact with BRI1 in vivo (3, 28, 38, 69) . Whereas the bak1 single lossof-function mutant shows a very weak dwarf phenotype, the bak1 serk1-1 double mutant shows a significantly enhanced BR-insensitive dwarf phenotype, and the bak1-4 bkk1-1 double mutant shows an only slightly enhanced de-etiolation phenotype compared to bak1 itself. It was recently proposed that SERK1 and BAK1/SERK3, but not BKK1/SERK4, mediate BR response (3). However, the phenotype of the bak1 serk1 double mutant is still much weaker than the strong bri1 alelles or than transgenic plants expressing a dominant negative form of bak1 (52) . The analysis might have been complicated by the additional roles of BAK1 and BKK1 in pathways that suppress cell death.
Genetic studies have revealed additional roles of BAK1 and other members of the SERK family in multiple signaling pathways. First, BAK1 and BKK1/SERK4 are involved in controlling a light-dependent cell death process (27) . The bak1 bkk1 double mutant displays a seedling-lethal phenotype in the light but not in the dark. Many aspects of cell death phenotypes, including the upregulation of defenserelated genes and the accumulation of callose and H 2 O 2 , were observed in the bak1 bkk1 double mutant but not in each single mutant or in the bri1 null mutant, indicating that BAK1 and BKK1 play a redundant role in a pathway that suppresses cell death independently of BR signaling (28) . Second, BAK1 plays a key role in pathogenesis. The bak1 mutant displayed enhanced susceptibility to necrotrophic pathogen infection (41) . The application of BR suppresses only growth defects but not the disease phenotype of the bak1 mutant, supporting the hypothesis that BAK1 has a BR-independent role in defense (41) . In addition, the bak1 mutant shows reduced sensitivity to pathogenassociated molecular patterns (PAMPs) such as flagellin, EF-Tu, INF1, and CSP22. It was further revealed that BAK1 interacts with the flagellin receptor FLS2, another LRR-RLK protein, upon flagellin treatment (10) . These results indicate that BAK1 also functions as a coreceptor of FLS2 for flagellin signaling. Shan and coworkers (78) reported that virulence factors of bacterial pathogen target BAK1 to overcome the host defense system and to inhibit BR signaling as well. The transgenic plants overexpressing the bacterial effector AvrPto show dwarf phenotypes that mimic weak bri1 mutants, and AvrPto and AvrPtoB interact with BAK1, leading to disruption of FLS2-BAK1 association (78) . Third, SERK1 and SERK2 play a redundant role in male sporogenesis. The serk1 serk2 double mutant is male sterile due to a defect in tapetum development in the anther (2, 14) .
Taken together, it has been shown that the four members of the SERK family play overlapping roles in at least four distinct pathways: BAK1, SERK1, and BKK1/SERK4 in BR signaling; BAK1 and BKK1/SERK4 in cell death control; BAK1 in flagellin signaling and innate immunity; and SERK1 and SERK2 in male sporogenesis (3). Members of a gene family were likely generated by gene duplication, which initially created copies of genes that were fully redundant. How different SERK members gain or retain specific functions is an interesting evolutionary question. Functional specificity can be generated by changes in the promoter or coding sequences, resulting in diverse tissuespecific gene expression or protein activity. Expression of SERK3 from the SERK1 or SERK2 promoter failed to rescue the male-sterility phenotype of serk1 serk2 double mutant, suggesting that the protein specifies the function in this case (3) . In contrast, the BRI1 homologs appear to have gained functional specificity by changes in the promoters and gene expression patterns, as expression of BRL1 from the BRI1 promoter rescued the bri1 mutant (8) .
It should be noted that dual function was also reported for tomato BRI1, which was shown to bind systemin, a peptide hormone for wounding response (72, 73) ; however, this finding was later disputed (32, 33, 55) . The more recent studies concluded that tomato BRI1 is required for BR signaling but not for systemin signaling (33, 55) . Similarly, progesterone was shown to bind to the same G-protein-coupled receptor as the peptide oxytocin in certain animal cells (23) , but this finding was also later disputed (4, 7).
Regulation by Auto-and Transphosphorylation
To understand the signaling mechanisms of BRI1 and BAK1, several recent studies have identified phosphorylation sites in their kinase domains, mostly by using mass spectrometry (MS) (39, 64, 90, 91, 99) (Figure 1 ). The in vitro phosphorylation sites were identified by analyzing the recombinant intracellular domains expressed and purified from the bacterium Escherichia coli, and in vivo phosphorylation sites were identified by analyzing epitope-tagged BRI1 or BAK1 proteins immunoprecipitated from transgenic Arabidopsis plants. These studies identified eleven unambiguous phosphorylation sites in BRI1 (six identified in vivo and five identified only in vitro). MS data also supported the presence of additional phosphorylation sites that could not be assigned to specific amino acid residues, including at least three sites in the activation loop between domains VII and VIII. In addition, site-directed mutagenesis followed by phosphopeptide mapping provided the evidence for phosphorylation on additional residues (S1162) (92) . Although initial MS analyses identified only phosphorylation of Ser/Thr residues, a recent study using phosphopeptidespecific antibodies and MS analysis provided convincing evidence that BRI1 is also phosphorylated at tyrosine residues in vitro and in vivo, indicating that BRI1 is a dual-specificity kinase (64) . Interestingly, many other LRRRLKs, e.g., BAK1 and BKK1, also contain phosphorylation at tyrosine residues (64).
The functions of many identified or putative phosphorylation sites in BRI1 have been studied using site-directed mutagenesis followed by in vitro kinase assays and in planta rescue of the bri1 mutants (64, 90, 91) . These studies confirmed an important role of phosphorylation in the activation loop for the kinase activity of BRI1. Mutations of S1044/T1045, T1049, Y1052, or Y1057 nearly abolished BRI1's kinase activity in vitro and its ability to rescue the bri1-5 mutant. Mutations of two additional Tyr residues (Y956 or Y1072) outside the activation loop also abolished the kinase activity, though phosphorylation of Y1072 has not been detected in vivo.
Important function was also demonstrated for phosphorylation in the JM and CT domains of BRI1. Deletion of the JM domain from BRI1 abolished its signaling function and ability to rescue the bri1-5 mutant phenotype, without affecting its localization at the plasma membrane (92) . Seven phosphorylation sites in the JM domain were identified as autophosphorylation sites in vitro and in vivo by MS analysis (63, 90) . Of these, the phosphomimetic substitutions of four phosphorylation sites (S838D, T842D, T846D, and S858D) enhanced the phosphorylation of a BRI1 synthetic peptide substrate in the absence of BAK1, indicating that phosphorylation of the JM domain activates BRI1 (91) . However, the action mechanism by which the JM domain modulates BRI1 activity remains unclear.
By contrast, deletion of the CT domain increases the kinase activity of BRI1 in vitro and in vivo and promotes hypocotyl growth of bri1-5 and det2 mutant more effectively than wild type BRI1 (92) . Multiple Ser/Thr residues of the CT domain are phosphorylated. At least four Ser/Thr residues (S-1162, S-1166, S-1168, and T-1180) among eight possible sites in the CT domain were experimentally confirmed (90) (91) (92) . Multiple substitutions of Ser/Thr residues to Asp in the CT domain increase BRI1 kinase activity independent of BAK1 activity (91) . Moreover, mutant BRI1 containing phosphomimetic mutations in the CT domain more effectively suppressed the dwarf phenotype of det2 (91, 92) . These results demonstrated that the CT domain of BRI1 is autoinhibitory of BRI1 kinase and this inhibitory effect is alleviated by phosphorylation (92) . The functions of the JM and CT domains of BRI1 demonstrate that noncatalytic regions of the cytoplasmic domain play important roles in specifically modulating kinase activity. It is well known that nonkinase intracellular domains of mammalian receptor kinases play important roles not only in autoregulation but also in creating binding sites for substrates in a phosphorylationdependent manner (35, 36) . Thus, it is possible that JM and CT of BRI1 are involved in regulating kinase activity as well as creating binding sites for BRI1 downstream substrates.
A total of nine phosphorylation sites have been identified in the intracellular region of BAK1; five of them were identified in vivo (S290, T312, T446, T449, and T455) and four in vitro (S286, T450, S604, and S612) (39, 91, 92, 99) . Unlike BRI1, BAK1 is mainly phosphorylated in the activation loop (T446, T449, T450, and T455) (91), although two phosphorylation sites (S-604 and S-612) in the CT domain were recently detected in vitro (39) . The phosphorylation of the T455 residue, corresponding to T1049 of BRI1 in the activation loop of BAK1, is essential for BAK1 function, since mutation of T455A abolished the kinase activity (91) . Although single mutation of the other phosphorylation sites in the activation loop had little effect on BAK1 activity, changing all three Thr to Ala (T446A/T449A/T450A) abolished the kinase activity (91, 99) , indicating that phosphorylation in the activation loop is critical for BAK1 kinase activity.
While analyses of the in vitro autophosphorylation and in vivo phosphorylation sites elucidated important residues at which phosphorylation affects kinase activity and signaling function, the mechanisms of BR regulation of these phosphorylation events remain unclear. Recently, it has been proposed that BR-induced association between BRI1 and BAK1 is a result of initial activation of the BRI1 kinase (91) , and sequential transphosphorylation between BRI1 and BAK1 activates both receptor kinases.
BR-induced association between BRI1 and BAK1 requires kinase activity of BRI1 but not that of BAK1, since BR increases the interaction between wild type BRI1 and kinase-dead mutant BAK1 but not between mutant BRI1 and wild type BAK1. Although the mutant BRI1 still shows basal level of interaction with BAK1, this interaction is not increased by BR treatment (91) . In addition, BR-induced BAK1 phosphorylation is enhanced by BRI1 overexpression but abolished in the bri1 null mutant. By contrast, BRI1 phosphorylation is still induced by BR treatment even in the bak1 bkk1 (serk3 serk4) double mutant background, though at a reduced degree compared with the wild type or BAK1-overexpressing plants. Prephosphorylation of BRI1 by BAK1 in vitro increases BRI1 phosphorylation of a BRI1-specific substrate, indicating that BRI1 has basal activity that is further activated by BAK1 transphosphorylation (91) . Furthermore, overexpression of BRI1 rescues hypocotyl elongation of the bak1 bkk1 double mutant, whereas overexpression of BAK1 fails to suppress null bri1 mutants (91) . However, SERK1 might still provide a function in the bak1 bkk1 double mutant, because SERK1 also associates with BRI1 and contributes to BR signaling (3, 38) . As such, analysis of a bak1 bkk1 serk1 triple null mutant is still required to determine if BAK1 and related proteins play essential or supporting roles in BR activation of BRI1.
Transactivation between BRI1 and BAK1 is mediated by transphosphorylation. The transphosphorylation sites have been identified by using in vitro kinase assays performed with kinase-inactive mutant protein as the substrate for its wild type partner. MS analyses showed that BRI1 mainly phosphorylates the kinase domain of BAK1. Of six BAK1 residues (S290, T312, T446, T449, T450, and T455) transphosphorylated by BRI1, four Thr residues (T446, T449, T450, and T455) are located in the activation loop and required for the kinase activity and signaling function of BAK1 (91) . Mutation to Ala either of T455 alone or of T446, T449, and T450 together abolished the kinase activity of BAK1 (91, 99) . Therefore, phosphorylation of these residues by BRI1 is likely to activate BAK1.
In contrast to BRI1 phosphorylation of the BAK1 activation loop, BAK1 mainly transphosphorylates the JM and CT domains of mutant BRI1 (91) . Three phospho-residues in the JM domain (S838, T846, and S858) and two in the CT domain (S1166 and T1180) of BRI1 were identified as BAK1 transphosphorylation sites. In addition, phosphomimetic mutants of JM and CT domains showed increased BRI1 kinase activity (91) , and bri1 mutants carrying the Ser/Thr substitution to Ala in the JM domain were less effective than wild-type BRI1 in suppressing the short hypocotyl phenotype of the bri1-5 mutant. These results support the hypothesis that BAK1 activates BRI1 by phosphorylating the JM and CT domains (91) . Together, the results support a sequential phosphorylation model for BR-activation of the BRI1-BAK1 receptor kinases: BR binding induces a basal activation of BRI1 kinase, which then binds to BAK1 and phosphorylates BAK1 in the activation loop to activate BAK1; activated BAK1 then phosphorylates BRI1 in the JM and CT region to fully activate BRI1's kinase activity and signaling function through enhanced phosphorylation of downstream substrates.
While phosphorylation at most sites positively activates the kinases, mutagenesis studies also revealed phosphorylation sites that possibly inhibit kinase activity. The T872A mutation of BRI1 increased its kinase activity by over tenfold, due to an increased V max and reduced K m . The results suggest that phosphorylation at T872 has a negative regulatory effect on the kinase activity, although it is also possible that the substitution of Ala at this specific Thr residue changes the protein conformation to a more active state (90) . In addition, the S286D mutation abolished BAK1 activity in vitro and in vivo, although S286A mutation had little effect (91) . Phosphorylation of S286 was detected in vitro as a BAK1 autophosphorylation site. It remains unclear whether S286 is phosphorylated in vivo by BAK1 autophosphorylation as a desensitizing mechanism or by other kinases that modulate the BAK1 activity (91) .
In addition to affecting the kinase activity, some phosphorylation sites appear to mediate specific signaling output. Mutation of Y831F in the JM domain of BRI1 had no obvious effect on the kinase activity. Expression of mutant BRI1 Y831F rescued the growth phenotype of bri1-5 but caused larger leaves and early flowering, suggesting that phosphorylation of Y831 might provide signal output to leaf development and flowering regulation. In addition, BAK1 containing the T450A mutation in the activation loop could rescue the cell-death and dwarf phenotypes of the bak1 bkk1 double mutant but failed to rescue the flagellin-insensitive phenotype of the mutant (91). These results suggest that individual phosphorylation sites might affect specific signaling output.
Endocytosis of BRI1 and BAK1
In mammals and yeast, endocytosis is a common mechanism for delivering activated receptors from the plasma membrane (PM) to its downstream cellular targets or for clearing the receptors from the cell surface to terminate the signaling and desensitize the system (30, 56) . Endocytosis of BRI1 and BAK1 was first observed in cowpea protoplasts (69) , where endocytosis was accelerated by coexpression of BRI1 and BAK1. Recently, BRI1-GFP was observed in the endosomes in Arabidopsis root cells independently of BR treatment (22) . Brefeldin A (BFA), an inhibitor blocking transition from early to late endosomal compartments, induced the accumulation of BRI1-GFP in endosomal compartments. Interestingly, BFA-treatment activated BR signaling and caused dephosphorylation of BZR2/BES1 and inhibition of DWF4 expression (22) . In contrast, Endosidin1, a chemical affecting PM/endosome trafficking, resulted in the accumulation of BRI1-GFP in large intracellular bodies (68) but caused a dwarf phenotype similar to the bri1 mutant. BRI1 endocytosis appears not to be regulated by BR but is increased by overexpression of BAK1 in the protoplasts.
SERK1 is also internalized, and its internalization involves the KINASE-ASSOCIATED PROTEIN PHOSPHATASE (KAPP) (77) . KAPP contains a phosphopeptide-binding domain (FHA) and interacts with SERK1 in a kinase-activity-dependent manner. Coexpression of KAPP increased SERK1 internalization. Although both SERK1 and KAPP colocalize at the plasma membrane, a FRET signal that indicates their physical interaction was detected only in the intracellular vesicles. Thus, it has been proposed that KAPP controls SERK1 internalization (77) . KAPP also interacts with both BRI1 and BAK1 in a phosphorylationdependent manner (17) , since it did not interact with kinase-inactive mutant BRI1 (K911E) and BAK1 (T546A). The kapp bri1-5 double mutant showed increased BL sensitivity over the bri1-5 single mutant, suggesting that KAPP might be a negative regulator of BR signaling (17) . Whether KAPP inhibits BR signaling by dephosphorylating the receptor kinases or promoting their endocytosis remains to be studied.
While these results support the importance of correct localization of BRI1 for its signaling function, the function of BRI1 endocytosis remains unclear. Based on positive signaling from BFA-sensitive endosomal BRI1, it has been proposed that endocytosis provides additional surface space or proximity for interaction with cytoplasmic proteins, or traps ligand-receptor complexes in small vesicle enclosures to maintain BR signaling (22) . The latter scenario is likely to be important in the roots, where water can dilute extracellular signal molecules. In Arabidopsis, BRI1 is localized in the PM in most cells and endosomal BRI1 is observed primarily in root cells (20, 22) . On the other hand, we still do not know how BRI1 is removed from the cell surface, e.g., in mature tissues that stop growing (20) , and whether internalization could be involved in receptor degradation as shown for some receptors in animal systems (30) .
Regulation by BKI1
The activity of the BRI1/BAK1 receptor kinases is also regulated by additional interacting proteins. In addition to BAK1, several novel proteins have been identified as BRI1-interacting proteins by yeast twohybrid screens (61, 89) . One of these, the BRI1 KINASE INHIBITOR 1 (BKI1), was shown to negatively regulate BRI1 function. RNAi knockdown of BKI1 caused enhanced hypocotyl elongation, whereas overexpression of BKI1 resulted in a weak dwarf phenotype. In addition, BKI1 overexpression reduces the BZR2/BES1 dephosphorylation induced by BR treatment and alters BR-regulated gene expression, indicating that BKI1 is a negative regulator of BR signaling. BKI1 is localized at the plasma membrane in the absence of BR, but is rapidly relocalized into the cytosol upon BR treatment (89) . These observations suggest that BKI1 interacts with BRI1 at the plasma membrane to keep BRI1 in an inactive form. BKI1 inhibits BRI1 at least partly by blocking its interaction with BAK1, because incubation with BKI1 reduced BRI1 interaction with BAK1 in vitro. Upon initial BR activation of BRI1 kinase, BKI1 is phosphorylated by BRI1 and rapidly dissociated from BRI1, allowing BAK1 association and full activation of BRI1 (89) . In support of this hypothesis, forced constitutive localization of BKI1 to the plasma membrane by an artificial N-terminal myristoylation site enhanced the dwarf phenotype caused by overexpression of BKI1. These results demonstrated that BKI1 provides another level of control that keeps BRI1 at a basal level when BR levels are low.
SIGNALING OUTPUT FROM THE RECEPTOR KINASES
Signaling output from the BRI1-BAK1 receptor complex should be mediated by intracellular substrates of these kinases. In addition to BAK1 and BKI1, additional BRI1-interacting proteins have been identified and shown to be phosphorylated by BRI1, at least in vitro. These include the PM-localized TRANSTHYRETIN-LIKE (TTL) protein, the homolog of TGFβ-RECEPTOR-INTERACTING PROTEIN 1 (TRIP-1), and the BR SIGNALING KINASES (BSKs). While the mechanism of function remains to be established for TTL and TRIP-1, the BSKs have been shown to mediate signaling from BRI1 to downstream gene expression responses.
TTL interacts with BRI1 in yeast and is phosphorylated by BRI1 in vitro (61) . Overexpression of TTL caused dwarf phenotypes similar to weak bri1 mutants, and a ttl knockout mutant displayed enhanced BR sensitivity and plant growth, suggesting that TTL negatively regulates BR signaling via interaction with BRI1 kinase. TTL binds more strongly to active BRI1 kinase than to a mutant BRI1 lacking kinase activity (61) . This is directly opposite to BKI1, which binds more strongly to inactive forms of BRI1 kinase (89) . Based on the localization of TTL at the plasma membrane, it was proposed that TTL might mediate direct BR regulation of membrane activities that control cell elongation (61) . Whether TTL interaction with BRI1 affects downstream BR-responsive gene expression remains unknown.
TRIP-1 shares sequence similarity with the mammalian TGFβ receptor-interacting protein, which plays a role in TBFβ signaling but is also an essential subunit of the eIF3 eukaryotic translation initiation factor. TRIP-1 interacts with BRI1 in vitro and in vivo and is phosphorylated by BRI1 on at least three residues (T14, T89, and either T197 or S198) in vitro, suggesting that TRIP-1 is a cytoplasmic substrate of the BRI1 kinase. It was proposed that TRIP-1 might play a role in BR-mediated translational regulation (18); however, direct evidence for BR-regulation of protein translation is still lacking. Recently, quantitative proteomics analyses identified a large number of BR-regulated proteins, but a change at the protein level without a change in the level of the coding RNA has not been found (16) , except for the BR signaling components, which are regulated by phosphorylation at the posttranslational level.
Using two-dimensional difference gel electrophoresis, proteomic analyses of total protein samples identified only late response proteins, but analyses of phosphoprotein or plasma membrane fractions identified early BRresponse proteins that mediate BR signal transduction (83) . These include BAK1 and the
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PM-localized BR signaling kinases (BSK1 and BSK2), which are phosphorylated upon BR treatment (84) . BSKs belong to the cytoplasmic receptor-like kinase (RLCK) subfamily XII (80) , which includes 12 members, all containing an N-terminal kinase domain and a C-terminal tertratricopeptide motif. In Arabidopsis, RLKs are a large protein family with more than 610 members, and 25% of them contain no extracellular domain or transmembrane domain and are named RLCK (80) . BSK1 was phosphorylated by BRI1 but not by BAK1 in vitro and BRI1 phosphorylated a specific Ser residue (S-230) of BSK1. In vivo interaction between BRI1 and BSKs was detected by coimmunoprecipitation, and the amount of coimmunoprecipitation was reduced by BR treatment, suggesting that BSKs disassociate from BRI1 upon phosphorylation (84) . Although most of the knockout mutants of BSKs did not show an obvious phenotype, the bsk3 knockout plant showed reduced BR sensitivity and hypersensitivity to the BR biosynthetic inhibitor, BRZ. Overexpression of BSKs strongly suppressed the dwarf phenotype and restored BR-regulated gene expression in the bri1-5 mutant. Furthermore, overexpression of BSKs partially suppressed a bri1 null mutant but did not suppress homozygous bin2-1, indicating that BSKs are positive regulators acting downstream of BRI1 and upstream of BIN2 (84) .
BZR1 AND BZR2/BES1: KEY TRANSCRIPTION FACTORS FOR BR-REGULATED GENE EXPRESION
Genetic studies identified two homologous transcription factors as key components of the BR signaling pathway and demonstrated that BR regulates plant development by modulating the expression of nuclear genes. The brassinazole resistant 1 (bzr1-1D) mutant looked like wild type grown without BRZ when grown on the BR biosynthetic inhibitor, BRZ, in contrast to the de-eitolation phenotype of wild type seedlings (93) . The bzr1-1D mutant fully suppresses the de-etiolation phenotype and partly suppresses the dwarf phenotype of the bri1 mutant. BZR1 is a member of a plant-specific gene family with five additional members in Arabidopsis (Figure 2) . The Pro234 to Leu mutation in bzr1-1D stabilizes the protein, which causes constitutive BR responsive growth in the dark (93) . The exact amino acid change P to L mutation in BZR1's closest homolog BZR2 (88% identical amino acid sequence) was found in a bri1 suppressor mutant named bes1-D (bri1-EMS-suppressor 1), and thus BZR2 was also named BES1 (97) . Overexpression of BZR1 increased hypocotyl length and a T-DNA knockout mutant bzr2-1 shows a slight reduction in hypocotyl length (25, 93) . Furthermore, RNAi P P P P P P P P
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Figure 2
The structure of the transcription factor BZR1. suppression of BZR2/BES1 and its close homologs caused a dwarf phenotype (96) , indicating that BZR1 and BZR2/BES1 are positive regulators of the BR pathway with redundant roles. The BZR1 and BZR2/BES1 proteins were recently shown to be transcription factors that directly regulate BR-responsive gene expression (25, 96) . In one set of experiments, BZR1 fused to the DNA-binding domain of GAL4 was able to repress the transcription from a promoter-reporter gene containing GAL4 binding sites, demonstrating BZR1's transcription-repressor capacity. Chromatin-immunoprecipitation experiments demonstrated that BZR1 binds to the promoters of the BR-biosynthetic genes CPD and DWF4, which are rapidly suppressed by BR treatment as a mechanism for feedback regulation of BR biosynthesis. A series of in vitro DNA-binding experiments demonstrated that BZR1, through its N-terminal domain, directly bound optimally to the CGTGT/CG sequence, which is required for the CPD promoter to respond to BR and is thus named BR-response element (BRRE). Consistent with BZR1 repressing gene expression through BRRE, BRRE was found to be enriched in a large number of BR-repressed genes, including additional BR biosynthetic genes. Interestingly, BRRE is also slightly enriched in promoters of BR-induced genes. Because BZR1 plays dual roles in feedback inhibition of BR biosynthesis and BR promotion of plant growth, it is likely that BZR1 also activates certain promoters, possibly by interacting with different partners (25) .
In contrast to the transcription-repressing activity of BZR1, BZR2/BES1 was shown to activate a BR-induced gene SAUR-AC1 (96) . BZR2/BES1 interacts with a bHLH transcription factor named BIM1, and together they bind to the E-box (CANNTG) of the SAUR-AC1 promoter. Transient co-overexpression of BZR2/BES1 and BIM1 activates a SAUR-AC1 promoter-GUS reporter gene, indicating that BZR2/BES1 and BIM1 positively regulate SAUR-AC1 expression. While both BIM1 overexpression and knockdown experiments support a role in plant growth regulation, the phenotypes of these plants are subtle (96) . It is possible that additional bHLH proteins play redundant roles or that BIMs control only a subset of BR-regulated genes and developmental processes. In fact, a recent study identified two Jumonji domain-containing proteins, ELF6 and REF6, as additional BZR2/BES1-interacting proteins. Both proteins were previously found to regulate flowering (98) . Furthermore, BIM1 was shown to interact with two AP2/ERF transcription factors, DORN-ROSCHEN and DORNROSCHEN-LIKE, involved in embryo patterning, and the bim1 mutant also shows embryo-patterning defects at low penetrance (9) . These results suggest that BZR2/BES1 recruits other transcriptional regulators to modulate the expression of subsets of target genes and specific developmental processes.
The opposite transcription activities of BZR1 and BZR2/BES1 provide a possible explanation for the differences in the light-grown phenotypes of the bzr1-1D and bes1-D mutants. While both mutants were insensitive to BRZ and suppress bri1 mutants in the dark, they showed opposite phenotypes when grown in the light, with bzr1-1D being a semi-dwarf and bes1-D having long petioles and pale leaves, reminiscent of BR-treated plants (93, 97) . The dwarf phenotype of bzr1-1D can be rescued by BR treatment or overexpression of a BRbiosynthetic gene and is thus at least partly caused by excessive feedback inhibition of BR synthesis (25) . Opposite transcription activities would explain such opposite effects on cell elongation of the light-grown mutants. However, this would be inconsistent with the similar overall constitutive BR-response phenotype in the dark and under BR-deficient conditions. In fact, it has been reported that BZR2/BES1 also mediates feedback inhibition of CPD and DWF4 expression (57, 87) and that BZR1 also mediates activation of BR-induced genes (25) . Given the almost identical amino acid sequences of BZR1 and BZR2/BES1, especially in the DNAbinding domain, it is possible that BZR1 and BZR2/BES1 have similar DNA-binding and transcription activities but are expressed in different tissues and thus have different effects on BR production in BR source tissues and on cell elongation in BR target tissues. A detailed analysis of tissue-specific expression of BZR family members will shed light on their functional specification. Moreover, identification of all the direct target genes of BZR1 and BZR2/BES1 will be important for understanding the function of the BR signaling pathway.
REGULATION OF BZR1 AND BZR2/BES1 BY BIN2-MEDIATED PHOSPHORYLATION
As key transcription factors of the BR signaling pathway, BZR1 and BZR2/BES1 are tightly controlled by upstream BR signaling. BR treatment induces rapid dephosphorylation of BZR1 and BZR2/BES1, which can be detected as band shift in immunoblotting (26, 93, 97) . As such, BZR1 and BZR2/BES1 should be phosphorylated by a kinase that negatively regulates BR response. Such a kinase has been identified by the second BR-insensitive mutant bin2.
In addition to bri1, bin2 (also named dwf12 or ucu1) is another locus identified based on BRinsensitive dwarf phenotypes. Unlike bri1 mutants, bin2 mutants are due to semi-dominant gain-of-function mutations (11, 51, 66) . BIN2 encodes a protein kinase that shares 70% sequence similarity to the mammalian Glycogen Synthase Kinase-3 (GSK3). GSK3s are conserved in all eukaryotes from yeast to humans and play important roles in a wide range of signaling pathways, usually as a negative regulator. Overexpression of BIN2 caused a dwarf phenotype similar to that of bin2-1, and loss-offunction of BIN2 and its homologs increases cell elongation and partially suppresses the bri1-5 mutant, indicating an inhibitory role for BIN2 in BR signaling (50, 95) .
Several lines of evidence demonstrate that BIN2 negatively regulates BR signaling by phosphorylating BZR1 and BZR2/BES1. First, the bzr1-1D and bes1-D mutations fully suppress the bin2-1 mutant phenotype, supporting the idea that BZR1 and BZR2/BES1 are downstream of BIN2 in the BR signaling pathway (93, 97) . Second, BIN2 interacts directly with BZR1 and BZR2/BES1 in yeast and in vitro (93, 97, 100) . Third, BIN2 effectively phosphorylates BZR1 and BZR2/BES1 in vitro, causing a mobility shift that is opposite to that caused by BR treatment of plants. Fourth, BZR1 and BZR2/BES1 are more phosphorylated and accumulate at a reduced level in the bin2-1 mutant (93, 97) . Furthermore, inhibition of BIN2 by chemical inhibitors, such as LiCl and bikinin, causes dephosphorylation of BZR1 and BZR2/BES1 (15, 95) . There are about 25 putative GSK3 phosphorylation sites conserved in BZR1, BZR2/BES1, and the rice homolog OsBZR1, and these phosphorylation sites appear to provide multiple mechanisms for regulating the transcription factors.
BIN2 phosphorylation has multiple inhibitory effects on the function of BZR1 and BZR2/BES1. First, phosphorylated BZR1 undergoes 26S proteasome-mediated degradation, since treatment with the proteasome inhibitor MG132 causes accumulation of the phosphorylated BZR1 but not the dephosphorylated form. While there have been conflicting observations of whether BR treatment affects the accumulation of BZR2/BES1 (86, 97) , BZR2/BES1 level is much reduced in the bri1 and bin2-1 mutants (97). Second, phosphorylation of BZR1 and BZR2/BES1 inhibits their DNA-binding activity. The BIN2-phosphorylated BZR1 and BZR2/BES1 fail to bind to DNA fragments derived from CPD or SAUR-AC1 promoter in vitro, and the transcriptional activity of BZR2/BES1 in yeast was suppressed in the presence of BIN2 (21, 86) . Third, phosphorylation of S173 causes binding to 14-3-3 proteins, which reduce nuclear localization of BZR1 and BZR2/BES1 (21) .
There have been controversial observations of whether BR induces nuclear localization of BZR1 and BZR2/BES1 (21, 86, 93, 97, 100) . The discrepancy is likely to reflect nonuniform responses of different cells or cells under different growth conditions (21) . For example, BR rapidly increases the ratio of nuclear to cytoplasmic BZR1 in hypocotyls of young seedlings, but the effect is less pronounced in mature seedlings. Subcellular fractionation experiments revealed association of phosphorylated BZR1 with plasma membranes, suggesting retention of phospho-BZR1 in the cytoplasm (21) . Furthermore, studies in both Arabidopsis and rice confirmed the important role of the 14-3-3 proteins in cytoplasmic localization of phosphorylated BZR factors (5, 21, 70) .
Yeast two-hybrid screens identified five of the fourteen Arabidopsis 14-3-3 proteins as BZR1-interacting proteins and all eight rice 14-3-3 proteins as OsBZR1-interacting proteins (5, 21). 14-3-3s are phosphopeptidebinding proteins that are highly conserved in all eukaryotes (6) . They are involved in numerous signaling pathways and regulate many cellular processes in yeast and mammals (6) . In plants, 14-3-3 proteins are known to regulate metabolic enzymes, ion channels, and response to hormones such as abscisic acid and gibberellins (76). 14-3-3s interact with target proteins in a sequence-specific and phosphorylation-dependent manner. They bind to two types of specific sequences: mode I, RXXpSXP, or mode II, RXXXpSXP (X = any amino acid, R = arginine, pS = phosphoserine, and P = proline), in which the S residue needs to be phosphorylated (1, 58) . BZR1, BZR2/BES1, and OsBZR1 all contain a conserved 14-3-3 binding motif (amino acids 169-175 of BZR1: RISNSCP), in which the required S173 of BZR1 is phosphorylated by BIN2 in vitro (5, 21) . Mutations of S173A of BZR1 and S156A of OsBZR1 abolish 14-3-3 binding in vitro and in vivo. Expression of BZR1-S173A and OsBZR1-S156A in transgenic Arabidopsis caused constitutive BR response phenotypes similar to the bzr1-1D mutant, indicating that binding by the 14-3-3 proteins inhibits BZR1 function (5, 21, 70) . These mutant proteins seem to have normal DNA-binding activity and stability in plant cells but show increased accumulation in the nucleus and reduced levels in the cytoplasm (5, 21, 70) . Furthermore, treatment with the 14-3-3 inhibitor AICAR (5-aminoimidazole-4-carboxamide-1-b-d-ribofuranoside) also increases the nuclear accumulation of BZR1-YFP protein and reduces the expression level of BZR1-repressed target genes CPD and DWF4 (21) . Another study using the protoplast system also demonstrated that BIN2-mediated phosphorylation regulates nucleocytoplasmic shuttling of BZR1 and the 14-3-3 binding site and another phosphorylation domain are involved in the regulation (70) . Taken together, these studies provide convincing evidence for an essential role of the phosphorylationdependent and 14-3-3 protein-mediated cytoplasmic localization of the BZR factors in BR signal transduction. The 14-3-3 proteins are likely to increase cytoplasmic localization of phospho-BZR1 by promoting both nuclear exporting and cytoplasmic retention (21, 70) .
The Arabidopsis genome contains 10 GSK3-like kinases, also named AtSKs (Arabidopsis thaliana Shaggy-like Kinases), which can be divided into four subgroups. Recent studies show that three AtSKs (AtSK21, AtSK22, and AtSK23/BIN2) belonging to subgroup II function redundantly in BR signaling. Their triple loss-of-function mutant shows elongated petiole and BRZ-resistant phenotype. However, considerable amounts of phosphorylated BZR2/BES1 are still present in the triple mutant, indicating that other AtSKs might be involved in BR signaling (86, 95) . Indeed, yeast two-hybrid assay using nine AtSKs covering all four subgroups shows that all six AtSKs belonging to subgroup I and II bind to BZR1 (42) . Further study of AtSK12, a member of subgroup I, demonstrated that AtSK12 interacts with BZR1 in vivo and phosphorylates BZR1 in vitro and is inactivated by BR treatment (42) . Thus, it is believed that at least six AtSKs can play negative roles in BR signaling by phosphorylating BZR1.
In addition to BZR1 and BZR2/BES1, BIN2 also phosphorylates the ARF2 transcription factor (88) . ARF2 is a transcriptional repressor that negatively regulates BR and auxin responses, possibly by competing with activator ARFs that promote auxin-induced gene expression.
Loss-of-function arf2 mutant shows reduced sensitivity to BR inhibitor, BRZ, suggesting a negative role of ARF2 in BR-mediated growth. BIN2 alleviated ARF2 transcriptional repression activity and inhibited its DNA-binding activity in vitro (88) . It was proposed that BIN2 inactivates ARF2 to promote BR and auxin (88) . However, as a negative regulator of BR signaling, BIN2 is inactivated by BR (42, 65) , which would lead to BR activation of ARF2. This seems contradictory to the negative role of ARF2 in hypocotyl elongation but would be consistent with ARF2's positive role in promoting stamen elongation and leaf senescence (19) . The mechanism of ARF2 regulation by BR signaling and the function of ARF2 in BR response require further study.
REGULATION OF BIN2 BY BSU1-MEDIATED TYROSINE DEPHOSPHORYLATION AND PROTEASOME-MEDIATED DEGRADATION
It is believed that BR induces dephosphorylation of BZR factors by inhibiting BIN2, but how BIN2 is inactivated by upstream BR signaling has remained an outstanding question. In animal systems, GSK3β plays a role in Wnt signaling similar to BIN2's role in BR signaling. GSK3β phosphorylates β-catenin to promote its degradation and cytoplasmic retention, similar to BIN2 regulation of BZR1/2. In mammals, GSK3β action is modulated by phosphorylation in its N-terminal domain, protein complex formation, and by priming phosphorylation of its substrate (54) . However, these mechanisms seem not to be used in BIN2 regulation of the BR signaling pathway (48) . A 12-amino-acid BIN2-binding motif in BZR1/2 functions as a docking site for BIN2, though it remains unclear whether BR regulates BIN2-BZR1/2 binding (48). Meanwhile, Peng and coworkers (65) have reported that BR induces rapid degradation of BIN2, which is blocked by MG132, the inhibitor of the 26S proteasome. Interestingly, the bin2-1 mutant protein accumulates in plants and is not degraded upon BR treatment, providing genetic evidence for an important role for BIN2 degradation by the proteasome in BR signaling. However, the primary mechanism that triggers BIN2 degradation was not identified (65) .
Recently, Kim and coworkers (42) detected BR-induced dephosphorylation of BIN2 using immuno-blotting following two-dimensional gel electrophoresis. This result indicated that a protein phosphatase might be involved in the regulation of BIN2. This phosphatase turned out to be BSU1 (bri1 SUPPRESSOR 1), which was initially thought to mediate dephosphorylation of BZR2/BES1. BSU1 was identified by activation tagging screening for suppressors of a weak bri1-5 allele (57) . BSU1 contains an N-terminal kelchrepeat domain and a C-terminal phosphatase domain homologous to protein phosphatase 1 (PP1). Overexpression of BSU1 suppresses a bri1 mutant and causes accumulation of dephosphorylated BZR2/BES1. RNAi suppression of BSU1 homologs caused a weak dwarf phenotype (57) . Quadruple loss-of-function of BSU1 family members, by T-DNA knockout of bsu1 bsl1, and RNAi suppression of BSL2 and BSL3 caused an extreme dwarf phenotype similar to the bri1 null mutant, confirming a positive role of BSU1 in BR signaling (42) .
When BZR1 or BZR2/BES1 and BIN2 were mixed with BSU1 in vitro, BZR1 or BZR2/BES1 phosphorylation was reduced by BSU1. However, the effect of BSU1 in the in vitro assay was mild, and it was proposed that BSU1 might dephosphorylate BZR1 and BZR2/BES1 to activate BR responses in vivo but need to be activated by posttranslational modification or by a partner protein (46, 57) . However, Kim and coworkers recently found that recombinant BSU1 or the immunopurified plant BSU1 does not dephosphorylate BZR1 that was prephosphorylated by BIN2, if BIN2 was removed before adding BSU1 (42) . Reduced phosphorylation of BZR1 and BZR2/BES1 was observed only when BIN2 was present with BSU1, as reported originally (42, 57) . Using BZR1 incompletely phosphorylated by 32 P-ATP to distinguish dephosphorylation from further phosphorylation by cold ATP, it was shown that BSU1 inhibits BIN2 phosphorylation but does not dephosphorylate BZR1 directly. Furthermore, BSU1 inhibition of wild type BIN2 is increased by BR treatment of the plants from which BSU1 was immunopurified, suggesting that BR signaling activates BSU1. BSU1 fails to inhibit phosphorylation of BZR1 by the mutant bin2-1, which causes BR-insensitive phenotypes in planta. Similar to BR treatment, overexpression of BSU1 reduces the level of BIN2 protein but not of bin2-1 (42) . BSU1 overexpression suppresses bri1 null allele but not homozygous bin2-1, although it partly suppresses the dwarf phenotype of heterozygous bin2-1. These results demonstrate that BSU1 functions downstream of BRI1 but upstream of BIN2 (42) . It was further shown that BSU1 interacts with BIN2 in vitro and in vivo (42) .
Mass spectrometry analysis of recombinant BIN2 identified Tyr200 as an autophosphorylation site (42) . Tyr200 is absolutely conserved in all GSK3s and phosphorylation at this site is required for kinase activity of BIN2 as it is for mammalian GSK3s. The Tyr200-Phe substitution abolished the ability of BIN2 and bin2-1 to cause a dwarf phenotype when overexpressed in transgenic Arabidopsis, suggesting that phosphorylation of Tyr200 is essential for BIN2 function in vivo. The level of Tyr200 phosphorylation of wild type BIN2 protein was reduced by incubation with BSU1 in vitro and by BR treatment of plants in vivo (42) . Interestingly, Tyr200 phosphorylation of mutant bin2-1 protein was not affected by BSU1 in vitro or by BR treatment in vivo, indicating that the primary effect of the bin2-1 mutation is to block BSU1 dephosphorylation of Tyr200. These results further demonstrate that BSU1-mediated dephosphorylation of Tyr200 is the primary mechanism by which BR signaling inactivates BIN2 (42) . It was also shown that Tyr233 of AtSK12 (corresponding to Tyr200 of BIN2) is also dephosphorylated upon BR treatment.
Thus, BSU1-mediated Tyr200 dephosphorylation appears to be a general mechanism for inactivating GSK3s in BR signaling (42) .
Placing BSU1 upstream of BIN2 raised a possibility that BSU1 might directly interact with BSKs at the plasma membrane, which would close the last gap in the BR signaling pathway. Although BSU1 is primarily localized in the nucleus, small amounts of BSU1 can be observed in the cytoplasm (42, 57) . Microscopic observation and proteomic studies revealed that the BSU1 homologs (BSL1, BSL2, and BSL3) are localized at the plasma membrane and in the cytoplasm, raising the possibility of direct interaction with components localized at the plasma membrane (42) . Indeed, in vitro interaction assays showed that BSU1 specifically interacts with BSK1 but not with BRI1 and BAK1 (42) . This interaction was increased by BRI1 phosphorylation of BSK1 and abolished by mutation of the BRI1 phosphorylation site in BSK1 (S230A). In vivo interaction between BSU1 and BSK1 was also confirmed by coimmunoprecipitation and BiFC assays (42) . These results show that BRI1 phosphorylation of S230 of BSK1 promotes interaction with BSU1 (42) . As such, all major BR signaling components from cell surface receptor BRI1 kinase to nuclear transcription factors are now physically connected. The completed BR signaling pathway illustrates the molecular details of sequential signaling events: BR binding to BRI1 at the cell surface, BRI1 kinase activation by ligand-induced association and transphosphorylation with the BAK1 coreceptor and dissociation of the BKI1 inhibitor, BRI1 phosphorylation of BSKs, activation of BSU1, inactivation of BIN2 by BSU1-catalyzed tyrosine dephosphorylation, and nuclear accumulation of dephosphorylated BZR factors and BR-responsive gene expression (42) .
As the first complete signal transduction pathway mediated by a receptor kinase in plants (Figure 3) , the BR signaling pathway provides a paradigm for understanding plant signal transduction. Many signaling mechanisms revealed in the BR pathway are likely used broadly in other pathways. For example, the mechanism of BRI1-BAK1 kinase activation by ligand induced oligomerization and transphosphorylation is likely shared by other RLKs. The regulation of GSK3-like kinases through tyrosine dephosphorylation by BSU1 (a PP1-related phosphatase) is likely a conserved mechanism used in mammals, because phosphorylation of the same tyrosine residue also affects the activity of mammalian GSK3s and PP1 also plays a role in the Wnt signaling pathway upstream of GSK3β. The regulation of BIN2 and BRI1 by tyrosine phosphorylation clearly establishes the role of tyrosine phosphorylation as a common mechanism of signal transduction in plants. Although homologs of animal tyrosine kinases have not been found in plants, many plant kinases seem to have dual specificity for Ser/Thr and Tyr.
CONCLUDING REMARKS
The combination of genetics, biochemistry, and proteomics approaches has contributed to rapid progress toward a deep understanding of the BR signaling mechanism. The completed BR signaling pathway illustrates the molecular details of sequential signaling events: BR binding to BRI1 at the cell surface, BRI1 kinase activation by ligand-induced association and transphosphorylation with the BAK1 coreceptor and dissociation of the BKI1 inhibitor, BRI1 phosphorylation of BSKs, activation of BSU1, inactivation of BIN2 by BSU1-catalyzed tyrosine dephosphorylation, and nuclear accumulation of dephosphorylated BZR factors and BRresponsive gene expression. However, many more questions are yet to be answered. For example, how is BSU1 activity regulated by BSKs? What kind of phosphatase dephosphorylates BZR1/BES1 and how is it regulated by BR signaling? Do any BR signaling kinases and phosphatases directly regulate any cellular processes independent of the transcriptional pathway? Yet the more exciting and challenging question is how such a linear signaling pathway regulates diverse developmental and physiological responses. Identification of direct target genes of BZR1 and BZR2/BES1 is key for identifying downstream branch pathways leading to specific responses and for dissecting the transcriptional network that integrates with other signaling pathways. Ultimately, we will need to understand the operation of the BR signaling pathway in the context of tissue, organ, and whole plant development (44, 45, 71) . Most important though, the knowledge of BR function needs to be applied to genetic engineering that improves food and bio-energy production. The brassinosteroid signal transduction pathway. The signaling components in active and inactive status are shown in pink and blue, respectively. Phosphorylation confers positive effects (yellow circles) and negative effects (red circles). (a) In the absence of BR, BKI1 interacts with inactive forms of BRI1, leading to interruption of BRI1 binding to BAK1. BRI1-bound BSKs are kept in inactive status. Consequently, BSU1 is inactive. Active BIN2 (harboring phospho-tyrosine at the 200th amino acid residue) constitutively phosphorylates BZR1 and BZR2/BES1, leading to nuclear exporting and cytoplasmic retention by the 14-3-3 proteins, loss of DNA-binding activity, and proteasomal degradation of BZR1 and BZR2/BES1. (b) In the presence of BR, BR binds to BRI1, which induces association with BAK1 and disassociation of BKI1. By sequential transphosphorylation between BRI1 and BAK1, BRI1 is fully activated and phosphorylates BSKs. Then the phosphorylated BSKs are released from the receptor complex and bind to BSU1, presumably to enhance BSU1 activity. Activated BSU1 inhibits BIN2 through dephosphorylation of the phospho-tyrosine residue of BIN2, which allows accumulation of unphosphorylated BZR1 and BZR2/BES1 in the nucleus. Active BZR1 and BZR2/BES1 bind to genomic DNA to regulate BR-target gene expression, thereby modulating growth and development of plants.
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